These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6762533)

  • 1. Guanadrel sulfate compared with methyldopa for mild and moderate hypertension.
    Nugent CA; Palmer JD; Ursprung JJ
    Pharmacotherapy; 1982; 2(6):378-83. PubMed ID: 6762533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanadrel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension.
    Finnerty FA; Brogden RN
    Drugs; 1985 Jul; 30(1):22-31. PubMed ID: 3896742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanadrel sulfate: a postganglionic sympathetic inhibitor for the treatment of mild to moderate hypertension.
    Palmer JD; Nugent CA
    Pharmacotherapy; 1983; 3(4):220-9. PubMed ID: 6351026
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of guanadrel and guanethidine efficacy and side effects.
    Malinow SH
    Clin Ther; 1983; 5(3):284-9. PubMed ID: 6850722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanadrel. A new antihypertensive drug.
    Dunn MI; Dunlap JL
    JAMA; 1981 Apr; 245(16):1639-42. PubMed ID: 7206175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
    Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-titration trial of guanadrel as step-two therapy in essential hypertension.
    Oren A; Rotmensch HH; Vlasses PH; Riley LJ; Koplin JR; Latini V; Ferguson RK
    J Clin Pharmacol; 1985; 25(5):343-6. PubMed ID: 4031111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
    Joshi RC; De A; Cameron EG
    Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
    [No Abstract]   [Full Text] [Related]  

  • 10. Indapamide in ambulant treatment of hypertension: a comparative study with alpha-methyldopa.
    Meine H
    Postgrad Med J; 1981; 57 Suppl 2():37-8. PubMed ID: 7322958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of guanoclor and methyldopa in the treatment of severe hypertension.
    Mackinnon J; el-Baz LM
    Br J Clin Pract; 1971 Mar; 25(3):135-7. PubMed ID: 4929159
    [No Abstract]   [Full Text] [Related]  

  • 12. Guanabenz versus methyldopa in the therapy of mild-to-moderate hypertension.
    Rosendorff C
    S Afr Med J; 1982 Sep; 62(13):435-7. PubMed ID: 7051365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A within-patient comparison of bethanidine, methyldopa and propranolol in the treatment of hypertension.
    Prichard BN; Boakes AJ; Graham BR
    Clin Sci Mol Med Suppl; 1976 Dec; 3():567s-570s. PubMed ID: 799566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oxprenolol vs methyldopa as second-line antihypertensive agents in the elderly.
    Traub YM
    Arch Intern Med; 1988 Jan; 148(1):77-80. PubMed ID: 3276279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F; Widler J
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antihypertensive effect of guanfacine compared with methyldopa.
    van der Merwe CJ; Kruger SA
    S Afr Med J; 1980 Mar; 57(11):400-4. PubMed ID: 6105713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies of guanfacine and methyldopa.
    Roeckel A; Heidland A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):55S-59S. PubMed ID: 6994779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A controlled blind study of 4 antihypertensive agents (methyldopa and 3 sympatholytic agents)].
    Vejlsgaard V; Christensen M; Clausen E
    Ugeskr Laeger; 1967 May; 129(19):635-8. PubMed ID: 4877293
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of guanadrel in elderly hypertensive patients.
    Owens SD; Dunn MI
    Arch Intern Med; 1988 Jul; 148(7):1515-8. PubMed ID: 3382297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bethanidine, alpha-methyldopa, and reserpine in essential hypertension.
    Gibb WE; Malpas JS; Turner P; White RJ
    Lancet; 1970 Aug; 2(7667):275-7. PubMed ID: 4194359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.